439 related articles for article (PubMed ID: 10627478)
21. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
[TBL] [Abstract][Full Text] [Related]
22. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease.
Azuma H; Oomi H; Sasaki K; Kawabata I; Sakaino T; Koyano S; Suzutani T; Nunoi H; Okuno A
Blood; 1995 Jun; 85(11):3274-7. PubMed ID: 7756659
[TBL] [Abstract][Full Text] [Related]
23. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
[TBL] [Abstract][Full Text] [Related]
24. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox.
Raad H; Paclet MH; Boussetta T; Kroviarski Y; Morel F; Quinn MT; Gougerot-Pocidalo MA; Dang PM; El-Benna J
FASEB J; 2009 Apr; 23(4):1011-22. PubMed ID: 19028840
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
Kawai C; Yamauchi A; Kuribayashi F
Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
[TBL] [Abstract][Full Text] [Related]
27. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
28. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
[TBL] [Abstract][Full Text] [Related]
29. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
[TBL] [Abstract][Full Text] [Related]
30. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets.
Leto TL; Adams AG; de Mendez I
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10650-4. PubMed ID: 7938008
[TBL] [Abstract][Full Text] [Related]
31. The phagocyte 47-kilodalton cytosolic oxidase protein is an early reactant in activation of the respiratory burst.
Kleinberg ME; Malech HL; Rotrosen D
J Biol Chem; 1990 Sep; 265(26):15577-83. PubMed ID: 2168417
[TBL] [Abstract][Full Text] [Related]
32. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.
Campion Y; Paclet MH; Jesaitis AJ; Marques B; Grichine A; Berthier S; Lenormand JL; Lardy B; Stasia MJ; Morel F
Biochimie; 2007 Sep; 89(9):1145-58. PubMed ID: 17397983
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
[TBL] [Abstract][Full Text] [Related]
34. Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox.
Zhou H; Zhang F; Chen SH; Zhang D; Wilson B; Hong JS; Gao HM
Free Radic Biol Med; 2012 Jan; 52(2):303-13. PubMed ID: 22094225
[TBL] [Abstract][Full Text] [Related]
35. Taurine chloramine inhibits PMA-stimulated superoxide production in human neutrophils perhaps by inhibiting phosphorylation and translocation of p47(phox).
Choi HS; Cha YN; Kim C
Int Immunopharmacol; 2006 Sep; 6(9):1431-40. PubMed ID: 16846837
[TBL] [Abstract][Full Text] [Related]
36. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
[TBL] [Abstract][Full Text] [Related]
37. The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation.
Pessach I; Shmelzer Z; Leto TL; Dinauer MC; Levy R
J Leukoc Biol; 2006 Sep; 80(3):630-9. PubMed ID: 16844764
[TBL] [Abstract][Full Text] [Related]
38. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
[TBL] [Abstract][Full Text] [Related]
39. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
[TBL] [Abstract][Full Text] [Related]
40. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
